Robert J. Israel, Executive Vice President, Medi at PROGENICS PHARMACEUTICALS INC (PGNX), sold 9,000 shares at $7.00 ($63K) on 2014-11-21, disclosed to the SEC on 2014-11-21.
Scheduled sale ($63k) by Executive Vice President, Medi under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PGNX | SELL | 2015-03-13 | $14K | — | Filing → |
| PGNX | SELL | 2015-03-04 | $32K | — | Filing → |
| PGNX | SELL | 2015-01-13 | $14K | — | Filing → |